Yuan Guo
Zhengzhou, 450008, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
TACE Combined with Portal Vein Tumor Thrombus 125I Seed Implantation in the Treatment of HCC with Hepatic Arterioportal Shunts.
Journal: Journal of hepatocellular carcinoma
Published: May 27, 2024
Safety and efficacy of tract embolization using gelatin sponge particles in reducing pneumothorax after CT-guided percutaneous lung biopsy in patients with emphysema.
Journal: BMC pulmonary medicine
Published: March 16, 2024
Immune effect and prognosis of transcatheter arterial chemoembolization and tyrosine kinase inhibitors therapy in patients with hepatocellular carcinoma.
Journal: World journal of gastrointestinal oncology
Published: March 06, 2024
Useful genes for predicting the efficacy of transarterial chemoembolization in hepatocellular carcinoma.
Journal: Journal of cancer research and therapeutics
Published: January 17, 2023
Transarterial Chemoembolization Combined With Apatinib Plus PD-1 Inhibitors for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Multicenter Retrospective Study.
Journal: Clinical and translational gastroenterology
Published: December 07, 2022
Proteoglycan-4 predicts good prognosis in patients with hepatocellular carcinoma receiving transcatheter arterial chemoembolization and inhibits cancer cell migration in vitro.
Journal: Frontiers in oncology
Published: August 20, 2022
Plasma arginase-1 as a predictive marker for early transarterial chemoembolization refractoriness in unresectable hepatocellular carcinoma.
Journal: Frontiers in oncology
Published: August 08, 2022
Correlation of Serum Chemokine Ligand 14 with Barcelona Clinic Liver Cancer Stage, Lymphocyte Profile, and Response to Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma.
Journal: Journal of vascular and interventional radiology : JVIR
Published: May 05, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026